1246 related articles for article (PubMed ID: 12668987)
1. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
[TBL] [Abstract][Full Text] [Related]
2. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Vernon G; Baranova A; Younossi ZM
Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.
Browning JD; Szczepaniak LS; Dobbins R; Nuremberg P; Horton JD; Cohen JC; Grundy SM; Hobbs HH
Hepatology; 2004 Dec; 40(6):1387-95. PubMed ID: 15565570
[TBL] [Abstract][Full Text] [Related]
4. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
[TBL] [Abstract][Full Text] [Related]
5. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
Chalasani N; Younossi Z; Lavine JE; Diehl AM; Brunt EM; Cusi K; Charlton M; Sanyal AJ
Hepatology; 2012 Jun; 55(6):2005-23. PubMed ID: 22488764
[No Abstract] [Full Text] [Related]
6. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.
Ludwig J; Viggiano TR; McGill DB; Oh BJ
Mayo Clin Proc; 1980 Jul; 55(7):434-8. PubMed ID: 7382552
[TBL] [Abstract][Full Text] [Related]
8. The natural history of nonalcoholic fatty liver disease: a population-based cohort study.
Adams LA; Lymp JF; St Sauver J; Sanderson SO; Lindor KD; Feldstein A; Angulo P
Gastroenterology; 2005 Jul; 129(1):113-21. PubMed ID: 16012941
[TBL] [Abstract][Full Text] [Related]
9. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
Kleiner DE; Brunt EM; Van Natta M; Behling C; Contos MJ; Cummings OW; Ferrell LD; Liu YC; Torbenson MS; Unalp-Arida A; Yeh M; McCullough AJ; Sanyal AJ;
Hepatology; 2005 Jun; 41(6):1313-21. PubMed ID: 15915461
[TBL] [Abstract][Full Text] [Related]
10. Steatohepatitis: a tale of two "hits"?
Day CP; James OF
Gastroenterology; 1998 Apr; 114(4):842-5. PubMed ID: 9547102
[No Abstract] [Full Text] [Related]
11. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.
Donnelly KL; Smith CI; Schwarzenberg SJ; Jessurun J; Boldt MD; Parks EJ
J Clin Invest; 2005 May; 115(5):1343-51. PubMed ID: 15864352
[TBL] [Abstract][Full Text] [Related]
12. NAFLD: a multisystem disease.
Byrne CD; Targher G
J Hepatol; 2015 Apr; 62(1 Suppl):S47-64. PubMed ID: 25920090
[TBL] [Abstract][Full Text] [Related]
13. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.
Younossi ZM; Stepanova M; Afendy M; Fang Y; Younossi Y; Mir H; Srishord M
Clin Gastroenterol Hepatol; 2011 Jun; 9(6):524-530.e1; quiz e60. PubMed ID: 21440669
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of non-alcoholic fatty liver disease.
Bellentani S; Scaglioni F; Marino M; Bedogni G
Dig Dis; 2010; 28(1):155-61. PubMed ID: 20460905
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
Farrell GC; Larter CZ
Hepatology; 2006 Feb; 43(2 Suppl 1):S99-S112. PubMed ID: 16447287
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
Bedogni G; Miglioli L; Masutti F; Tiribelli C; Marchesini G; Bellentani S
Hepatology; 2005 Jul; 42(1):44-52. PubMed ID: 15895401
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of patients with NAFLD and elevated liver enzymes.
Ekstedt M; Franzén LE; Mathiesen UL; Thorelius L; Holmqvist M; Bodemar G; Kechagias S
Hepatology; 2006 Oct; 44(4):865-73. PubMed ID: 17006923
[TBL] [Abstract][Full Text] [Related]
18. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.
Powell EE; Cooksley WG; Hanson R; Searle J; Halliday JW; Powell LW
Hepatology; 1990 Jan; 11(1):74-80. PubMed ID: 2295475
[TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
Hamaguchi M; Kojima T; Takeda N; Nakagawa T; Taniguchi H; Fujii K; Omatsu T; Nakajima T; Sarui H; Shimazaki M; Kato T; Okuda J; Ida K
Ann Intern Med; 2005 Nov; 143(10):722-8. PubMed ID: 16287793
[TBL] [Abstract][Full Text] [Related]
20. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.
Angulo P; Hui JM; Marchesini G; Bugianesi E; George J; Farrell GC; Enders F; Saksena S; Burt AD; Bida JP; Lindor K; Sanderson SO; Lenzi M; Adams LA; Kench J; Therneau TM; Day CP
Hepatology; 2007 Apr; 45(4):846-54. PubMed ID: 17393509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
